Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

United Therapeutics Return on Investment 2011-2025 | UTHR

Current and historical return on investment (ROI) values for United Therapeutics (UTHR) over the last 10 years.
United Therapeutics ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2025-09-30 $1.50B 0.00%
2025-06-30 $1.45B 0.00%
2025-03-31 $1.40B 96.88%
2024-12-31 $1.38B 48.59%
2024-09-30 $1.28B 29.04%
2024-06-30 $1.26B $5.80B 21.20%
2024-03-31 $1.26B $5.54B 20.72%
2023-12-31 $1.18B $6.29B 19.23%
2023-09-30 $1.10B $6.21B 18.38%
2023-06-30 $1.09B $6.21B 18.83%
2023-03-31 $0.98B $5.92B 17.75%
2022-12-31 $0.98B $5.60B 18.62%
2022-09-30 $0.97B $5.36B 19.27%
2022-06-30 $0.89B $5.12B 18.25%
2022-03-31 $0.91B $4.98B 19.34%
2021-12-31 $0.56B $4.76B 12.30%
2021-09-30 $0.45B $4.63B 10.30%
2021-06-30 $0.44B $4.44B 10.45%
2021-03-31 $0.36B $4.25B 8.82%
2020-12-31 $0.59B $4.20B 14.92%
2020-09-30 $0.59B $4.08B 15.70%
2020-06-30 $0.56B $3.89B 15.32%
2020-03-31 $0.64B $3.75B 18.20%
2019-12-31 $-0.19B $3.38B -5.54%
2019-09-30 $-0.12B $3.47B -3.63%
2019-06-30 $-0.15B $3.36B -4.82%
2019-03-31 $-0.16B $3.37B -5.16%
2018-12-31 $0.81B $3.04B 28.24%
2018-09-30 $0.81B $2.94B 30.31%
2018-06-30 $0.99B $2.82B 50.70%
2018-03-31 $0.86B $2.62B 69.12%
2017-12-31 $0.82B $2.35B 138.78%
2017-09-30 $0.85B 0.00%
2017-06-30 $0.77B 0.00%
2017-03-31 $0.96B 0.00%
2016-12-31 $1.06B 0.00%
2016-09-30 $1.04B 0.00%
2016-06-30 $1.19B 0.00%
2016-03-31 $1.08B 0.00%
2015-12-31 $0.70B 0.00%
2015-09-30 $0.72B 0.00%
2015-06-30 $0.30B 0.00%
2015-03-31 $0.31B 0.00%
2014-12-31 $0.54B 0.00%
2014-09-30 $0.33B 0.00%
2014-06-30 $0.47B 0.00%
2014-03-31 $0.42B 0.00%
2013-12-31 $0.29B 86.30%
2013-09-30 $0.45B 66.25%
2013-06-30 $0.43B 42.81%
2013-03-31 $0.41B $1.36B 31.61%
2012-12-31 $0.42B $1.36B 33.02%
2012-09-30 $0.36B $1.26B 28.76%
2012-06-30 $0.38B $1.21B 31.21%
2012-03-31 $0.39B $1.29B 32.80%
2011-12-31 $0.32B $1.21B 28.70%
2011-09-30 $0.27B $1.15B 25.80%
2011-06-30 $0.23B $1.07B 30.23%
2011-03-31 $0.18B $0.99B 35.97%
2010-12-31 $0.17B $0.95B 39.72%
2010-09-30 $0.15B 42.44%
2010-06-30 $0.10B 19.51%
2010-03-31 $0.04B $0.76B 5.14%
2009-12-31 $0.03B $0.68B 3.58%
2009-09-30 $-0.11B $0.67B -13.44%
2009-06-30 $-0.10B $0.85B -13.65%
2009-03-31 $-0.08B $0.82B -14.80%
2008-12-31 $-0.08B $0.79B -18.30%
2008-09-30 $0.04B $0.45B 17.56%
2008-06-30 $0.04B 15.76%
2008-03-31 $0.03B $0.55B 8.03%
2007-12-31 $0.01B 1.86%
2007-09-30 $0.02B $0.46B 4.12%
2007-06-30 $0.02B $0.43B 3.85%
2007-03-31 $0.02B $0.40B 5.31%
2006-12-31 $0.03B $0.46B 8.82%
2006-09-30 $0.04B $0.28B 12.33%
2006-06-30 $0.04B $0.30B 14.21%
2006-03-31 $0.04B $0.29B 14.98%
2005-12-31 $0.04B $0.28B 18.44%
2005-09-30 $0.04B $0.24B 18.35%
2005-06-30 $0.03B $0.22B 15.17%
2005-03-31 $0.02B $0.20B 12.35%
2004-12-31 $0.01B $0.19B 7.92%
2004-09-30 $0.00B $0.18B 2.34%
2004-06-30 $0.00B $0.17B -2.37%
2004-03-31 $-0.01B $0.17B -6.53%
2003-12-31 $-0.01B $0.17B -7.07%
2003-09-30 $-0.01B $0.17B -6.43%
2003-06-30 $-0.02B $0.17B -9.28%
2003-03-31 $-0.01B $0.17B -7.92%
2002-12-31 $-0.02B $0.17B -9.86%
2002-09-30 $-0.03B $0.18B -13.25%
2002-06-30 $-0.03B $0.19B -15.31%
2002-03-31 $-0.04B $0.19B -20.72%
2001-12-31 $-0.05B $0.20B -22.72%
2001-09-30 $-0.07B $0.21B -31.22%
2001-06-30 $-0.07B $0.22B -29.00%
2001-03-31 $-0.09B $0.23B -41.16%
2000-12-31 $-0.08B $0.24B -44.75%
2000-09-30 $-0.07B $0.25B -53.14%
2000-06-30 $-0.07B $0.12B -77.09%
2000-03-31 $-0.04B $0.13B -58.67%
1999-12-31 $-0.04B $0.06B -80.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $19.772B $2.877B
United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by Eli Lilly as Cialis for erectile dysfunction) tablets.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $80.531B 30.59
Zoetis (ZTS) United States $52.936B 18.95
Takeda Pharmaceutical (TAK) Japan $44.579B 9.10
Daiichi Sankyo, - (DSNKY) Japan $41.884B 20.86
BeOne Medicines - (ONC) Switzerland $37.686B 199.80
Sandoz Group AG (SDZNY) Switzerland $30.065B 0.00
Merck (MKKGY) Germany $16.918B 11.00
Summit Therapeutics (SMMT) United States $14.775B 0.00
Neurocrine Biosciences (NBIX) United States $14.686B 35.24
Shionogi (SGIOY) Japan $14.581B 13.39
IPSEN (IPSEY) France $12.599B 0.00
Madrigal Pharmaceuticals (MDGL) United States $12.298B 0.00
Ionis Pharmaceuticals (IONS) United States $11.735B 0.00
Orion OYJ (ORINY) Finland $9.625B 27.50
Corcept Therapeutics (CORT) United States $8.311B 89.78
Eisai (ESAIY) $8.236B 0.00
Stevanato Group S.p.A (STVN) Italy $7.320B 40.97
Grifols, S.A (GRFS) Spain $6.002B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.204B 15.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.586B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.493B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.075B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.753B 17.84
Hypermarcas (HYPMY) Brazil $3.123B 23.48
Centessa Pharmaceuticals (CNTA) United Kingdom $3.018B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.839B 9.06
Dyne Therapeutics (DYN) United States $2.809B 0.00
Soleno Therapeutics (SLNO) United States $2.616B 0.00
Ocular Therapeutix (OCUL) United States $2.390B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.067B 24.50
Guardian Pharmacy Services (GRDN) United States $1.979B 38.11
Avadel Pharmaceuticals (AVDL) Ireland $1.828B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.522B 90.38
Ardelyx (ARDX) United States $1.489B 0.00
Harrow (HROW) United States $1.435B 88.04
Collegium Pharmaceutical (COLL) United States $1.417B 7.02
Amylyx Pharmaceuticals (AMLX) United States $1.393B 0.00
Xeris Biopharma Holdings (XERS) United States $1.234B 0.00
Nektar Therapeutics (NKTR) United States $1.205B 0.00
Oruka Therapeutics (ORKA) United States $1.171B 0.00
Enliven Therapeutics (ELVN) United States $1.163B 0.00
Relay Therapeutics (RLAY) United States $1.090B 0.00
Xencor (XNCR) United States $1.062B 0.00
Evotec AG (EVO) Germany $1.055B 0.00
Cronos Group (CRON) Canada $0.965B 0.00
Theravance Biopharma (TBPH) United States $0.932B 39.36
ARS Pharmaceuticals (SPRY) United States $0.867B 0.00
Organogenesis (ORGO) United States $0.825B 0.00
ProKidney (PROK) United States $0.824B 0.00
Savara (SVRA) United States $0.748B 0.00
Esperion Therapeutics (ESPR) United States $0.741B 0.00
Aquestive Therapeutics (AQST) United States $0.694B 0.00
Elite Pharmaceuticals (ELTP) United States $0.694B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.689B 6.15
Bioventus (BVS) United States $0.637B 13.05
4D Molecular Therapeutics (FDMT) United States $0.617B 0.00
KalVista Pharmaceuticals (KALV) United States $0.580B 0.00
Zevra Therapeutics (ZVRA) United States $0.531B 0.00
Lexeo Therapeutics (LXEO) United States $0.492B 0.00
Akebia Therapeutics (AKBA) United States $0.480B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.469B 11.11
Siga Technologies (SIGA) United States $0.450B 6.17
Altimmune (ALT) United States $0.447B 0.00
Galectin Therapeutics (GALT) United States $0.355B 0.00
Nature's Sunshine Products (NATR) United States $0.350B 20.83
USANA Health Sciences (USNA) United States $0.348B 9.70
Lyell Immunopharma (LYEL) United States $0.331B 0.00
Aldeyra Therapeutics (ALDX) United States $0.315B 0.00
Korro Bio (KRRO) United States $0.308B 0.00
Larimar Therapeutics (LRMR) United States $0.300B 0.00
Pyxis Oncology (PYXS) United States $0.285B 0.00
Achieve Life Sciences (ACHV) Canada $0.254B 0.00
Aclaris Therapeutics (ACRS) United States $0.249B 0.00
Journey Medical (DERM) United States $0.238B 0.00
OmniAb (OABI) United States $0.232B 0.00
Heron Therapeutics (HRTX) United States $0.213B 0.00
AleAnna (ANNA) United States $0.210B 0.00
Protara Therapeutics (TARA) United States $0.207B 0.00
MediWound (MDWD) Israel $0.205B 0.00
Avalo Therapeutics (AVTX) United States $0.204B 0.00
Profound Medical (PROF) Canada $0.194B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
China SXT Pharmaceuticals (SXTC) China $0.161B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.154B 0.00
Cassava Sciences (SAVA) United States $0.150B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.128B 0.00
Incannex Healthcare (IXHL) Australia $0.125B 0.00
Inhibikase Therapeutics (IKT) United States $0.122B 0.00
Avita Medical (RCEL) United States $0.121B 0.00
Context Therapeutics (CNTX) United States $0.109B 0.00
Relmada Therapeutics (RLMD) United States $0.109B 0.00
Surrozen (SRZN) United States $0.104B 0.00
Cardiol Therapeutics (CRDL) Canada $0.103B 0.00
Gain Therapeutics (GANX) United States $0.097B 0.00
Champions Oncology (CSBR) United States $0.096B 35.00
Karyopharm Therapeutics (KPTI) United States $0.093B 0.00
Vivani Medical (VANI) United States $0.090B 0.00
Assertio Holdings (ASRT) United States $0.089B 0.00
Dominari Holdings (DOMH) United States $0.087B 0.00
VAXART, INC (VXRT) United States $0.085B 0.00
Unicycive Therapeutics (UNCY) United States $0.085B 0.00
Metagenomi (MGX) United States $0.083B 0.00
Plus Therapeutics (PSTV) United States $0.078B 0.00
Prelude Therapeutics (PRLD) United States $0.076B 0.00
Lite Strategy (LITS) United States $0.074B 0.00
Nutriband (NTRB) United States $0.073B 0.00
PMV Pharmaceuticals (PMVP) United States $0.070B 0.00
Rafael Holdings (RFL) United States $0.066B 0.00
Acrivon Therapeutics (ACRV) United States $0.065B 0.00
BioNxt Solutions (BNXTF) Canada $0.063B 0.00
Talphera (TLPH) United States $0.060B 0.00
PolyPid (PYPD) Israel $0.060B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Fractyl Health (GUTS) United States $0.055B 0.00
Wellgistics Health (WGRX) United States $0.053B 0.00
ElectroCore (ECOR) United States $0.050B 0.00
Arch Biopartners (ACHFF) Canada $0.050B 0.00
NRx Pharmaceuticals (NRXP) United States $0.049B 0.00
Telomir Pharmaceuticals (TELO) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
Jupiter Neurosciences (JUNS) United States $0.046B 0.00
Tempest Therapeutics (TPST) United States $0.043B 0.00
FibroGen (FGEN) United States $0.040B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.039B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Inotiv (NOTV) United States $0.036B 0.00
Klotho Neurosciences (KLTO) United States $0.036B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.035B 0.00
Liminatus Pharma (LIMN) United States $0.032B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.030B 25.00
Iterum Therapeutics (ITRM) Ireland $0.029B 0.00
Scienture Holdings (SCNX) United States $0.026B 0.00
Cosmos Health (COSM) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
SCYNEXIS (SCYX) United States $0.025B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Vyome Holdings (HIND) United States $0.019B 0.00
TherapeuticsMD (TXMD) United States $0.019B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Mangoceuticals (MGRX) United States $0.018B 0.00
Heatwurx (PCSA) United States $0.018B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Ainos (AIMD) United States $0.015B 0.00
BioLineRx (BLRX) Israel $0.015B 0.00
Traws Pharma (TRAW) United States $0.013B 0.02
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
BioVie (BIVI) United States $0.011B 0.00
ProPhase Labs (PRPH) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
VYNE Therapeutics (VYNE) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
CDT Equity (CDT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 15.85
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00